Home Lung Cancer Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC)

HERTHENA-Lung01 Study of Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC

A first patient has been dosed in HERTHENA-Lung01, a phase II study evaluating patritumab deruxtecan, a HER3 directed DXd...

X